Royal Marsden Partners

Showing 46 to 60 of 234

• Board packPan-London Acute Myeloid Leukaemia January 2020Part of the archive, included with a subscription1 Jan 2020
• Board packPan-London Myelodysplastic Syndromes January 2020Part of the archive, included with a subscription1 Jan 2020
• Board packPan-London Plasma Cell Disorders January 2020Part of the archive, included with a subscription1 Jan 2020
• Board packPan-London Less Common Lymphoid Malignancies January 2020Part of the archive, included with a subscription1 Jan 2020
• Board paperPan-London Chronic Lymphocytic Leukaemia and B-prolymphocytic Leukaemia January 2020Part of the archive, included with a subscription1 Jan 2020
• Board packPan-London Diffuse Large B Cell Lymphoma JanuaryPart of the archive, included with a subscription1 Jan 2020
• Board packPan-London Hodgkin Lymphoma January 2020Part of the archive, included with a subscription1 Jan 2020
• Board packPan-London Myeloproliferative Neoplasms January 2020Part of the archive, included with a subscription1 Jan 2020
• Board packPan-London Acute Lymphoblastic Leukaemia January 2020Part of the archive, included with a subscription1 Jan 2020
• Board packIpsos Mori early diagnosis interventions evaluation November 2019.Part of the archive, included with a subscription1 Nov 2019
• Board paperPan-London Follicular Lymphoma September 2018Part of the archive, included with a subscription1 Sept 2018
• Board paperLondon Living With and Beyond Cancer: Metrics Definitions June 2017Part of the archive, included with a subscription1 Jun 2017
• Board packLCA Sexual Consequences of Cancer Treatment Management Pathway March 2016Part of the archive, included with a subscription1 Mar 2016
• Board paperLCA guidance on GI consequences of cancer March 2016Part of the archive, included with a subscription1 Mar 2016
• Board paperLCA Lymphoedema Service Specification January 2016 (updated March 2016)Part of the archive, included with a subscription1 Jan 2016